Description
Springer Soft Tissue Sarcomas 1st Editon 2011 Softbound by Laurence H. Baker
Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdivisions such as lung cancer, genitour inary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more. 1. Changing concepts in pathology.- 2. Diagnostic strategy for adult soft tissue sarcomas.- 3. Staging of soft tissue sarcomas.- 4. Surgical treatment of soft tissue sarcomas.- 5. Cyto reduction for soft tissue sarcomas.- 6. Adjuvant chemotherapy of adult soft tissue sarcomas.- 7. Perfusion chemotherapy.- 8. Infusion chemotherapy for soft tissue sarcomas.- 9. Role of radiotherapy.- 10. Chemotherapy of disseminated soft tissue sarcomas.- 11. Phase II new drug trials in soft tissue sarcomas.